*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global antifungal drugs market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 4% during 2021-2026.

Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.

Antifungal Drugs Market Trends:

The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, drug class and indication.

Breakup by Drug Class:

  • Azoles
    • Voriconazole (Vfend)
    • Posaconazole (Noxafil)
    • Clotrimazole (Canesten)
    • Isavuconazole (CRESEMBA)
    • Others
  • Echinocandins
    • Caspofungin (Cancidas)
    • Micafungin (Mycamine/ Funguard)
    • Others
  • Polyenes
    • Amphotericin (AmBisome)
    • Others
  • Allylamines
    • Terbinafine (Lamisil)
    • Others
  • Others
     

Breakup by Indication:

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
    • Invasive Candidiasis
    • Vulvovaginal Candidiasis (VVC)
    • Mouth/Throat/Esophageal Candidiasis
    • Others
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Class, Indication, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global antifungal drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antifungal drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antifungal drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Antifungal Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Azoles
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Voriconazole (Vfend)
           6.1.2.2 Posaconazole (Noxafil)
           6.1.2.3 Clotrimazole (Canesten)
           6.1.2.4 Isavuconazole (CRESEMBA)
           6.1.2.5 Others
        6.1.3 Market Forecast
    6.2    Echinocandins
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Caspofungin (Cancidas)
           6.2.2.2 Micafungin (Mycamine/ Funguard)
           6.2.2.3 Others
        6.2.3 Market Forecast
    6.3    Polyenes
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Amphotericin (AmBisome)
           6.3.2.2 Others
        6.3.3 Market Forecast
    6.4    Allylamines
        6.4.1 Market Trends
        6.4.2 Key Segments
           6.4.2.1 Terbinafine (Lamisil)
           6.4.2.2 Others
        6.4.3 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Indication
    7.1    Dermatophytosis
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Aspergillosis
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Candidiasis
        7.3.1 Market Trends
        7.3.2 Key Segments
           7.3.2.1 Invasive Candidiasis
           7.3.2.2 Vulvovaginal Candidiasis (VVC)
           7.3.2.3 Mouth/Throat/Esophageal Candidiasis
           7.3.2.4 Others
        7.3.3 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbott Laboratories
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Arcadia Consumer Healthcare Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    Astellas Pharma Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bayer AG
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    GlaxoSmithKline Plc
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
        13.3.6    Merck & Co. Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Merck KGaA
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Novartis AG
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Pfizer Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Sanofi S.A.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Scynexis Inc.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials

List of Figures

Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2020
Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2020
Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2020
Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2020
Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Antifungal Drugs Market: Competitive Structure
Table 6: Global: Antifungal Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links